EGFR and neoplasm: Liao et al. [144] improved glioma treatment by administrating EGFR-tMB + US, resulting in increased tumor vessel permeability and enhanced tumor-suppressing effect 7 days after treatment, with no tumor regrowth in the following 10 days.